Go to
JCI Insight
Citations to this article
Abstract
Current therapies for pulmonary arterial hypertension (PAH) provide symptomatic relief and improve prognosis but fall short of improving long-term survival. There is emerging evidence for a role of inflammatory mediators, primarily IL-6, in the pathogenesis of PAH. However, the mechanisms by which IL-6 potentially affects PAH are unknown. In this issue of the JCI, Tamura, Phan, and colleagues identified ectopic upregulation of the membrane-bound IL-6 receptor (IL6R), indicating classical IL-6 signaling in the smooth muscle layer of remodeled vessels in human and experimental PAH. They performed a series of in vitro and in vivo experiments that provide deeper insights into the mechanisms of classical IL-6 signaling and propose interventions directed against IL6R as a potential therapeutic strategy for PAH.
Authors
Soni Savai Pullamsetti, Werner Seeger, Rajkumar Savai
Total citations by year
Citation information
Citations to this article (38)
| Title and authors | Publication | Year |
|---|---|---|
|
Inflammatory Indices and MAFLD Prevalence in Hypertensive Patients: A Large-Scale Cross-Sectional Analysis from China
Shen D, Cai X, Hu J, Song S, Zhu Q, Ma H, Zhang Y, Ma R, Zhou P, Yang W, Hong J, Zhang D, Li N |
Journal of Inflammation Research | 2025 |
|
Interleukin-6 Is a Crucial Factor in Shaping the Inflammatory Tumor Microenvironment in Ovarian Cancer and Determining Its Hot or Cold Nature with Diagnostic and Prognostic Utilities
Amer H, Flanagan KL, Kampan NC, Itsiopoulos C, Scott CL, Kartikasari AE, Plebanski M |
Cancers | 2025 |
|
A Lifelike guided journey through the pathophysiology of pulmonary hypertension—from measured metabolites to the mechanism of action of drugs
Weinstein N, Carlsen J, Schulz S, Stapleton T, Henriksen HH, Travnik E, Johansson PI |
Frontiers in Cardiovascular Medicine | 2024 |
|
Ethanol-induced lung and cardiac right ventricular inflammation and remodeling underlie progression to pulmonary arterial hypertension
Donovan MK, Abdel-Rahman AA |
2024 | |
|
Immunotherapy for Pulmonary Arterial Hypertension: From the Pathogenesis to Clinical Management
Zhang Y, Li X, Li S, Zhou Y, Zhang T, Sun L |
International journal of molecular sciences | 2024 |
|
Association between premature vascular smooth muscle cells senescence and vascular inflammation in Takayasu's arteritis.
Fang C, Du L, Gao S, Chen Y, Chen Z, Wu Z, Li L, Li J, Zeng X, Li M, Li Y, Tian X |
Annals of the rheumatic diseases | 2024 |
|
The hepcidin‐ferroportin axis influences mitochondrial function, proliferation, and migration in pulmonary artery endothelial and smooth muscle cells
Issitt T, Toe QK, Pedersen SL, Shackshaft T, Ghazaly MM, West L, Arnold ND, Mahomed A, Kagugube GW, Ramakrishnan L, Lawrie A, Quinlan GJ, Wort SJ |
Pulmonary Circulation | 2024 |
|
Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies
Amer H, Kampan NC, Itsiopoulos C, Flanagan KL, Scott CL, Kartikasari AE, Plebanski M |
Cancers | 2024 |
|
Significance of CCNs in liver regeneration.
Barkin JM, Jin-Smith B, Torok K, Pi L |
Journal of Cell Communication and Signaling | 2023 |
|
Varied hypoxia adaptation patterns of embryonic brain at different development stages between Tibetan and Dwarf laying chickens.
Tang Q, Yu R, Wang Y, Xie F, Zhang H, Wu C, Fang M |
BMC Genomics | 2023 |
|
Interleukin-6 and pulmonary hypertension: from physiopathology to therapy.
Xu WJ, Wu Q, He WN, Wang S, Zhao YL, Huang JX, Yan XS, Jiang R |
Frontiers in immunology | 2023 |
|
Senescent hepatic stellate cells promote liver regeneration through IL-6 and ligands of CXCR2
Naiyuan Cheng, Ki-Hyun Kim, Lester F. Lau |
JCI Insight | 2022 |
|
Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival
T Kudryashova, S Dabral, S Nayakanti, A Ray, D Goncharov, T Avolio, Y Shen, A Rode, A Pena, L Jiang, D Lin, J Baust, T Bachman, J Graumann, C Ruppert, A Guenther, M Schmoranzer, Y Grobs, S Lemay, E Tremblay, S Breuils-Bonnet, O Boucherat, A Mora, H DeLisser, J Zhao, Y Zhao, S Bonnet, W Seeger, S Pullamsetti, E Goncharova |
Circulation research | 2022 |
|
Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients
S Kaur, A Singh, J Kaur, N Verma, A Pandey, S Das, S Bhattacharyya, P Guchhait |
Blood cells, molecules & diseases | 2022 |
|
Activation Pathways that Promote CD4+ T Cells to Break Tolerance in Autoimmune Diseases
Krovi SH, Kuchroo VK |
Immunological Reviews | 2022 |
|
Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life
Selle J, Dinger K, Jentgen V, Zanetti D, Will J, Georgomanolis T, Vohlen C, Wilke R, Kojonazarov B, Klymenko O, Mohr J, v. Koningsbruggen-Rietschel S, Rhodes CJ, Ulrich A, Hirani D, Nestler T, Odenthal M, Mahabir E, Nayakanti S, Dabral S, Wunderlich T, Priest J, Seeger W, Dötsch J, Pullamsetti SS, Alejandre Alcazar MA |
Nature Communications | 2022 |
|
Pim-1 kinase is a positive feedback regulator of the senescent lung fibroblast inflammatory secretome
Gao AY, Diaz Espinosa AM, Gianì F, Pham TX, Carver CM, Aravamudhan A, Bartman CM, Ligresti G, Caporarello N, Schafer MJ, Haak AJ |
AJP Lung Cellular and Molecular Physiology | 2022 |
|
Lung Inflammation in Health and Disease, Volume I
YX Wang |
2021 | |
|
Interleukin-6 mediates neutrophil mobilization from bone marrow in pulmonary hypertension
J Florentin, J Zhao, YY Tai, SB Vasamsetti, SP ONeil, R Kumar, A Arunkumar, A Watson, J Sembrat, GC Bullock, L Sanders, B Kassa, M Rojas, BB Graham, SY Chan, P Dutta |
Cellular and Molecular Immunology | 2021 |
|
Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia
D Hirani, C Alvira, S Danopoulos, C Milla, M Donato, L Tian, J Mohr, K Dinger, C Vohlen, J Selle, S v. Koningsbruggen-Rietschel, V Barbarino, C Pallasch, S Rose-John, M Odenthal, G Pryhuber, S Mansouri, R Savai, W Seeger, P Khatri, D Alam, J Dötsch, M Alcazar |
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology | 2021 |
|
Autoimmunity in Pulmonary Arterial Hypertension: Evidence for Local Immunoglobulin Production
T Shu, Y Xing, J Wang |
Frontiers in Cardiovascular Medicine | 2021 |
|
Pemafibrate Pretreatment Attenuates Apoptosis and Autophagy during Hepatic Ischemia-Reperfusion Injury by Modulating JAK2/STAT3β/PPARα Pathway
Z Cheng, C Guo, C Lau |
PPAR Research | 2021 |
|
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing
L Marongiu, G Protti, FA Facchini, M Valache, F Mingozzi, V Ranzani, AR Putignano, L Salviati, V Bevilacqua, S Curti, M Crosti, ML Sarnicola, M D'Angiò, LR Bettini, A Biondi, L Nespoli, N Tamini, N Clementi, N Mancini, S Abrignani, R Spreafico, F Granucci |
European Journal of Immunology | 2021 |
|
Uncovering antiobesity-related hypertension targets and mechanisms of metformin, an antidiabetic medication
L Yang, J Yang, X Liang, W Huang, X Zhang, R Li |
Bioengineered | 2021 |
|
Bioinformatics and in-silico findings reveal medical features and pharmacological targets of biochanin A against colorectal cancer and COVID-19
J Qin, C Guo, L Yang, X Liang, A Jiao, K Lai, B Yang |
Bioengineered | 2021 |
|
Pathological Mechanisms and Potential Therapeutic Targets of Pulmonary Arterial Hypertension: A Review
Y Xiao, PP Chen, RL Zhou, Y Zhang, Z Tian, SY Zhang |
Aging and disease | 2020 |
|
Perivascular Inflammation in Pulmonary Arterial Hypertension
Y Hu, L Chi, WM Kuebler, NM Goldenberg |
Cells | 2020 |
|
Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets
H Karmouty-Quintana, RA Thandavarayan, SP Keller, S Sahay, LM Pandit, B Akkanti |
International journal of molecular sciences | 2020 |
|
The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice
M Batool, EM Berghausen, M Zierden, M Vantler, RT Schermuly, S Baldus, S Rosenkranz, H ten Freyhaus |
Basic Research in Cardiology | 2020 |
|
Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
P Sarode, MB Schaefer, F Grimminger, W Seeger, R Savai |
Frontiers in Oncology | 2020 |
|
Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension
J Nuche, TS de la Cal, CJ Guarch, F López-Medrano, CP Delgado, FA Ynsaurriaga, JF Delgado, B Ibáñez, E Oliver, PE Subías |
Diagnostics | 2020 |
|
Inhibition of the ROS-EGFR Pathway Mediates the Protective Action of Nox1/4 Inhibitor GKT137831 against Hypertensive Cardiac Hypertrophy via Suppressing Cardiac Inflammation and Activation of Akt and ERK1/2
S Zeng, Q Yan, L Yang, Q Mei, H Lu |
Mediators of Inflammation | 2020 |
|
Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment.
Zheng X, Mansouri S, Krager A, Grimminger F, Seeger W, Pullamsetti SS, Wheelock CE, Savai R |
2020 | |
|
The hallmarks of severe pulmonary arterial hypertension: the cancer hypothesis—ten years later
Cool CD, Kuebler WM, Bogaard HJ, Spiekerkoetter E, Nicolls MR, Voelkel NF |
AJP Lung Cellular and Molecular Physiology | 2020 |
|
Key inflammatory pathways underlying vascular remodeling in pulmonary hypertension
EM Berghausen, L Feik, M Zierden, M Vantler, S Rosenkranz |
Herz | 2019 |
|
Plexiform Arteriopathy in Rodent Models of Pulmonary Arterial Hypertension
BL Carman, DN Predescu, R Machado, SA Predescu |
The American Journal of Pathology | 2019 |
|
Novel Role of T Cells and IL-6 (Interleukin-6) in Angiotensin II–Induced Microvascular Dysfunction
EY Senchenkova, J Russell, A Yildirim, DN Granger, FN Gavins |
Hypertension | 2019 |
|
Inducible microRNA-590-5p inhibits host antiviral response by targeting the soluble interleukin-6 (IL6) receptor
Y Zhou, Z Xia, Z Cheng, G Xu, X Yang, S Liu, Y Zhu |
The Journal of biological chemistry | 2018 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)